Latest Treatments of Parkinson's Disease Stories

2008-09-01 06:00:07

Research and Markets (http://www.researchandmarkets.com/research/9a0ef4/cns_drug_discoveri) has announced the addition of the "CNS Drug Discoveries: Parkinson's Disease Chapter" report to their offering. This chapter of CNS Drug Discoveries focuses on the Parkinson's disease market.

2008-07-23 06:00:20

Depomed, Inc. (NASDAQ:DEPO) announced today that it has been awarded a preclinical grant by The Michael J. Fox Foundation under the foundation's Therapeutics Development Initiative 2008 Program.

2008-07-14 06:00:12

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced that results from the ADAGIO study will be presented at the 12th Congress of European Federation of Neurological Societies (EFNS) on August 26, 2008 in Madrid, Spain.

2008-06-16 15:00:07

By PETER GOTT Dear Dr. Gott: I was diagnosed with Parkinson's disease in June 2005. I take Mirapex, which is prescribed, and co-enzyme Q10, which is not. I read somewhere that Q10 is a good over-the-counter for people with Parkinson's disease.

2008-06-16 03:00:07

FDA APPROVES REQUIP(R) XL(TM), THE FIRST AND ONLY ORAL ONCE-DAILY NON-ERGOT DOPAMINE AGONIST FOR PARKINSON'S DISEASE Extended-Release Formulation Improved Symptoms in Patients Not Optimally Controlled with Levodopa and Reduced Patients'"Off" Time by Nearly Two Hours Per Day LONDON, UK, 16 June 2008 -- SkyePharma PLC (LSE: SKP) today announces that the United States Food and Drug Administration (FDA) has approved GlaxoSmithKline's (NYSE: GSK) Requip(R) XL(TM) (ropinirole extended-release...

2007-05-08 06:00:11

CAMBRIDGE, Mass. and WINNERSH, U.K., May 8, 2007 (PRIME NEWSWIRE) -- Biogen Idec (Nasdaq:BIIB) and Vernalis plc (Nasdaq:VNLS) (LSE:VER) today announced the initiation of the Phase II program of BIIB014 (also known as V2006), an oral compound, for the treatment of Parkinson's disease.

2005-12-27 14:16:16

NEW YORK (Reuters Health) - Genetically modified nerve 'progenitor' cells can be used as mini-pumps to deliver nerve growth factor to the brain, a new study in animals shows. The results suggest such an approach could be used to treat Parkinson's disease and other brain diseases in humans, Dr.

2005-08-24 16:44:57

A class of drugs known as MAO-B inhibitors may be effective in improving motor symptoms in people with early Parkinson’s disease and may delay the need for treatment with other drugs, according to a new systematic review of current evidence.

2005-08-24 14:39:00

NEW YORK (Reuters Health) - Drugs called dopamine agonists, used to treat Parkinson's disease, may trigger sudden uncontrollable somnolence in about one in five patients.

Word of the Day
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).